Skip to main content

Advertisement

SpringerLink
Log in

Multidetector CT predictors of incomplete resection in primary cytoreduction of patients with advanced ovarian cancer

  • Computed Tomography
  • Published:
European Radiology Aims and scope Submit manuscript

Abstract

This study was designed to develop a preoperative predictor model using multidetector CT (MDCT) imaging findings for the prediction of surgical outcome in patients with advanced epithelial ovarian cancer (EOC). Seventy-seven patients with advanced EOC who had preoperative MDCT and who had undergone primary cytoreductive surgery between January 1999 and June 2008 were enrolled in the study. All MDCT examinations were analysed retrospectively, assessing nine imaging features without knowledge of the operative findings. The complete debulking rate and optimal debulking rate were 42.5% and 93.2%, respectively. Based on the use of univariate and multivariate analysis, one imaging feature that showed the presence of upper abdominal ascites was significantly associated with incomplete tumour resection (P = 0.019 on univariate analysis, P = 0.04 on multivariate analysis). The combination of the MDCT findings that showed the presence of upper abdominal ascites and diffuse subdiaphragmatic peritoneal nodularity was associated with an incomplete resection of a tumour (P = 0.04; specificity 80.0%; positive predictive value 76.9%). It is important that emphasis on the upper abdominal sites of the tumour is helpful when reporting preoperative MDCT results.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ (2007) Cancer statistics, 2007. CA Cancer J Clin 57:43–66

    Article  PubMed  Google Scholar 

  2. Spencer JA (2005) A multidisciplinary approach to ovarian cancer at diagnosis. Br J Radiol 78(Spec No. 2):S94–S102

    Article  PubMed  Google Scholar 

  3. Cannistra SA (2004) Cancer of the ovary. N Engl J Med 351:2519–2529

    Article  CAS  PubMed  Google Scholar 

  4. Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ (2002) Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol 20:1248–1259

    Article  PubMed  Google Scholar 

  5. Chi DS, Liu JB, Leon LF, Venkatraman ES, Hensley ML, Bhaskaran D, Hoskins WJ (2001) Identification of prognostic factors in advanced epithelial ovarian carcinoma. Gynecol Oncol 82:532–537

    Article  CAS  PubMed  Google Scholar 

  6. Eisenkop SM, Spirtos NM (2001) What are the current surgical objectives, strategies, and technical capabilities of gynecologic oncologists treating epithelial ovarian cancer. Gynecol Oncol 82:489–497

    Article  CAS  PubMed  Google Scholar 

  7. Hoskins WJ, McGuire WP, Brady MF et al (1994) The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma. Am J Obstet Gynecol 170:974–979

    CAS  PubMed  Google Scholar 

  8. Hoskins WJ (1994) Epithelial ovarian carcinoma: principles of primary surgery. Gynecol Oncol 55:S91–S96

    Article  CAS  PubMed  Google Scholar 

  9. Aletti GD, Gostout BS, Podratz KC, Cliby WA (2006) Ovarian cancer surgical resectability: relative impact of disease, patient status, and surgeon. Gynecol Oncol 100:33–37

    Article  PubMed  Google Scholar 

  10. Chi DS, Franklin CC, Levine DA et al (2004) Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approach. Gynecol Oncol 94:650–654

    Article  PubMed  Google Scholar 

  11. Holschneider CH, Berek JS (2005) Cytoreductive surgery: Principles and rationale. In: Bristow RE, Karlan BY, Montz FJ (eds) Surgery for ovarian cancer: principles and practice. Parthenon, Lancaster, pp 141–143

    Google Scholar 

  12. Risum S, Hogdall C, Loft A et al (2008) Prediction of suboptimal primary cytoreduction in primary ovarian cancer with combined positron emission tomography/computed tomography—a prospective study. Gynecol Oncol 108:265–270

    Article  CAS  PubMed  Google Scholar 

  13. Eisenhauer EL, Abu-Rustum NR, Sonoda YA, ghajanian C, Barakat RR, Chi DS (2008) The effect of maximal surgical cytoreduction on sensitivity to platinum-taxane chemotherapy and subsequent survival in patients with advanced ovarian cancer. Gynecol Oncol 108:276–281

    Article  CAS  PubMed  Google Scholar 

  14. Kawamoto S, Urban BA, Fishman EK (1999) CT of epithelial ovarian tumors. Radiographics 19:S85–S102

    PubMed  Google Scholar 

  15. Forstner R, Hricak H, White S (1995) CT and MRI of ovarian cancer. Abdom Imaging 20:2–8

    Article  CAS  PubMed  Google Scholar 

  16. Bland AE, Ecerett EN, Pastore LM, Andersen WA, Taylor PT Jr (2008) Predictors of suboptimal surgical cytoreduction in women with advanced epithelial ovarian cancer treated with initial chemotherapy. Int J Gynecol Cancer 18:629–636

    Article  CAS  PubMed  Google Scholar 

  17. Chi DS, Schwartz PE (2008) Cytoreduction vs neoadjuvant chemotherapy for ovarian cancer. Gynecol Oncol 111:391–399

    Article  PubMed  Google Scholar 

  18. Qayyum A, Coakley FV, Westphalen AC, Hricak H, Okuno WT, Powell B (2005) Role of CT and MR imaging in predicting optimal cytoreduction of newly diagnosed primary epithelial ovarian cancer. Gynecol Oncol 96:301–306

    Article  PubMed  Google Scholar 

  19. Tempany CM, Zou KH, Silverman SG, Brown DL, Kurtz AB, McNeil BJ (2000) Staging of advanced ovarian cancer: comparison of imaging modalities—report from the Radiological Diagnostic Oncology Group. Radiology 215:761–767

    CAS  PubMed  Google Scholar 

  20. Pannu HK, Horton KM, Fishman EK (2003) Thin section dual-phase multidetector-row computed tomography detection of peritoneal metastases in gynecologic cancers. J Comput Assist Tomogr 27:333–340

    Article  PubMed  Google Scholar 

  21. Axtell AE, Lee MH, Bristow RE, Dowdy SC et al (2007) Multi-institutional reciprocal validation study of computed tomography predictors of suboptimal primary cytoreduction in patients with advanced ovarian cancer. J Clin Oncol 5:384–389

    Article  Google Scholar 

  22. Bristow RE, Duska LR, Lambrou NC, Fishman EK, O’Neill MJ, Trimble EL, Montz FJ (2000) A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography. Cancer 89:1532–1540

    Article  CAS  PubMed  Google Scholar 

  23. Salani R, Axtell A, Gerardi M, Holschneider C, Bristow RE (2008) Limited utility of conventional criteria for predicting unresectable disease in patients with advanced stage epithelial ovarian cancer. Gynecol Oncol 108:271–275

    Article  PubMed  Google Scholar 

  24. Omura GA, Brady MF, Homesley HD, Yordan E, Major FJ, Buchsbaum HJ, Park RC (1991) Long-term follow-up and prognostic factor analysis in advanced ovarian carcinoma: the Gynecologic Oncology Group experience. J Clin Oncol 9:1138–1150

    CAS  PubMed  Google Scholar 

  25. Makar AP, Baekelandt M, Trope CG, Kristensen GB (1995) The prognostic significance of residual disease, FIGO substage, tumor histology, and grade in patients with FIGO stage III ovarian cancer. Gynecol Oncol 56:175–180

    Article  CAS  PubMed  Google Scholar 

  26. Le T, Krepart GV, Lotocki RJ, Heywood MS (1997) Does debulking surgery improve survival in biologically aggressive ovarian carcinoma. Gynecol Oncol 67:208–214

    Article  CAS  PubMed  Google Scholar 

  27. Eisenkop SM, Friedman RL, Wang HJ (1998) Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: a prospective study. Gynecol Oncol 69:103–108

    Article  CAS  PubMed  Google Scholar 

  28. Bristow RE, Montz FJ (2001) Complete surgical cytoreduction of advanced ovarian carcinoma using the argon beam coagulator. Gynecol Oncol 83:39–48

    Article  CAS  PubMed  Google Scholar 

  29. Eisenkop SM, Spirtos NM, Friedman RL, Lin WC, Pisani AL, Perticucci S (2003) Relative influences of tumor volume before surgery and the cytoreductive outcome on survival for patients with advanced ovarian cancer: a prospective study. Gynecol Oncol 90:390–396

    Article  PubMed  Google Scholar 

  30. Chi DS, Eisenhauer EL, Lang J et al (2006) What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC). Gynecol Oncol 103:559–564

    Article  CAS  PubMed  Google Scholar 

  31. Mironov S, Akin O, Pandit–Taskar N, Hann LE (2007) Ovarian cancer. Radiol Clin North Am 45:149–166

    Article  PubMed  Google Scholar 

  32. Meyers MA (1970) The spread and localization of acute intraperitoneal effusions. Radiology 95:547–554

    CAS  PubMed  Google Scholar 

  33. Meyers MA (1975) Metastatic seeding along the small bowel mesentery. Roentgen features. Am J Roentgenol 123:67–73

    CAS  Google Scholar 

  34. Dowdy SC, Mullany SA, Brandt KR, Huppert BJ, Cliby WA (2004) The utility of computed tomography scans in predicting suboptimal cytoreductive surgery in women with advanced ovarian carcinoma. Cancer 101:346–352

    Article  PubMed  Google Scholar 

  35. Everett EN, Heuser CC, Pastore LM, Anderson WA, Rice LW, Irvin WP, Taylor PT (2005) Predictors of suboptimal surgical cytoreduction in women treated with initial cytoreductive surgery for advanced stage epithelial ovarian cancer. Am J Obstet Gynecol 193:568–574

    Article  PubMed  Google Scholar 

  36. Kundel HL, Polansky M (2003) Measurement of observer agreement. Radiology 228:303–308

    Article  PubMed  Google Scholar 

  37. Everett EN, French AE, Stone RL, Pastore LM, Jazaeri AA, Andersen WA, Taylor PT Jr (2006) Initial chemotherapy followed by surgical cytoreduction for the treatment of stage III/IV epithelial ovarian cancer. Am J Obstet Gynecol 195:568–576

    Article  PubMed  Google Scholar 

  38. Nelson BE, Rosenfield AT, Schwartz PE (1993) Preoperative abdominopelvic computed tomographic prediction of optimal cytoreduction in epithelial ovarian carcinoma. J Clin Oncol 11:166–172

    CAS  PubMed  Google Scholar 

  39. Meyer JI, Kennedy AW, Friedman R, Ayoub A, Zepp RC (1995) Ovarian carcinoma: value of CT in predicting success of debulking surgery. AJR Am J Roentgenol 165:875–878

    CAS  PubMed  Google Scholar 

  40. Chi DS, Franklin CC, Levine DA, Akselrod F, Sabbatini P, Jarnagin WR (2004) DeMatteo R, Poynor EA, Abu-Rustum NR, Barakat RR, Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approach. Gynecol Oncol 94:650–654

    Article  PubMed  Google Scholar 

  41. Bhoola S, Hoskins WJ (2006) Diagnosis and management of epithelial ovarian cancer. Obstet Gynecol 107:1399–1410

    PubMed  Google Scholar 

  42. Berek JS, Hacker NF, Lagasse LD, Nieberg RK, Elashoff RM (1983) Survival of patients following secondary cytoreductive surgery in ovarian cancer. Obstet Gynecol 61:189–193

    CAS  PubMed  Google Scholar 

  43. Bertelsen K (1990) Tumor reduction surgery and long-term survival in advanced ovarian cancer: a DACOVA study. Gynecol Oncol 38:203–209

    Article  CAS  PubMed  Google Scholar 

  44. Colombo PE, Mourregot A, Fabbro M et al (2009) Aggressive surgical strategies in advanced ovarian cancer: A monocentric study of 203 stage IIIC and IV patients. Eur J Surg Oncol 35:135–143

    PubMed  Google Scholar 

  45. Huober J, Meyer A, Wagner U, Wallwiener D (2002) The role of neoadjuvant chemotherapy and interval laparotomy in advanced ovarian cancer. J Cancer Res Clin Oncol 128:153–160

    Article  CAS  PubMed  Google Scholar 

  46. Carnino F, Fuda G, Ciccone G, Iskra L, Guercio E, Dadone D, Conte PF (1997) Significance of lymph node sampling in epithelial carcinoma of the ovary. Gynecol Oncol 65:467–472

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported by the National Cancer Centre, South Korea (Grant Nos. 0810110–01 and 0910140–1).

Author information

Authors and Affiliations

  1. Department of Radiology, Research Institute and Hospital, National Cancer Center, Goyang, Republic of Korea

    Dae Chul Jung, Min Ju Kim & Hyun Beom Kim

  2. Department of Gynecology, Research Institute and Hospital, National Cancer Center, 111 Jungbalsan-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do, 410–769, Republic of Korea

    Sokbom Kang & Sang Yoon Park

Authors
  1. Dae Chul Jung
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sokbom Kang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Min Ju Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sang Yoon Park
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hyun Beom Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sokbom Kang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jung, D.C., Kang, S., Kim, M.J. et al. Multidetector CT predictors of incomplete resection in primary cytoreduction of patients with advanced ovarian cancer. Eur Radiol 20, 100–107 (2010). https://doi.org/10.1007/s00330-009-1533-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00330-009-1533-0

Keywords

Search

Navigation